Hillrom Acquires Bardy Diagnostics
January 19, 2021
Hillrom (NYSE: HRC) agreed to acquire Bardy Diagnostics, Inc. (BardyDx) for $375 million in cash plus potential milestone payments, expanding Hillrom's digital health and ambulatory cardiac monitoring capabilities. The deal brings Hillrom a wearable ECG platform (the CAM patch), approximately $30 million in annualized revenue, and about 230 employees; Hillrom expects the acquisition to be dilutive in year one and accretive thereafter.
- Buyers
- Hillrom
- Targets
- Bardy Diagnostics, Inc.
- Industry
- Medical Devices
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Baxter Completes Acquisition of Hillrom
December 13, 2021
Medical Devices
Baxter International has completed its acquisition of Hillrom, paying $156.00 per share for a purchase price of $10.5 billion (approximately $12.5 billion enterprise value including assumed debt). The deal brings Hillrom's products and digital health capabilities into Baxter's portfolio to expand global reach, drive connectivity and analytics-enabled care, and pursue cost synergies and growth opportunities.
-
CardioOne Acquires CardioDiagnostics
April 24, 2025
Healthcare Services
CardioOne, a national growth and operational partner for independent cardiology practices, has acquired CardioDiagnostics, a provider of advanced ECG and remote patient monitoring (RPM) technologies. The deal integrates CardioDiagnostics’ cloud-based monitoring, analytics and RPM capabilities into CardioOne’s practice management platform to expand virtual care and enhance cardiology practice services.
-
Hologic, Inc. Acquires Mobidiag Oy
June 17, 2021
Medical Devices
Hologic, Inc. has completed the acquisition of Mobidiag Oy, a Finnish developer of near‑patient molecular diagnostic instruments and tests, for approximately $808 million. The deal expands Hologic's diagnostics capabilities by adding Mobidiag's Amplidiag and Novodiag platforms for rapid, multiplexed acute‑care testing and broadens Hologic's global diagnostics footprint.
-
Royal Philips to Acquire BioTelemetry, Inc. for $2.8B
December 18, 2020
Healthcare Services
Royal Philips has agreed to acquire BioTelemetry, Inc. in a cash tender offer of USD 72.00 per share, implying an enterprise value of approximately USD 2.8 billion. The deal combines Philips' hospital patient-monitoring capabilities with BioTelemetry's remote cardiac diagnostics and monitoring services (which serve over 1 million patients annually and had 2019 sales of about USD 439 million) to expand Philips' patient care management offerings across hospital and home settings.
-
Hologic Acquires Bolder Surgical for $160 Million
October 14, 2021
Medical Devices
Hologic, Inc. agreed to acquire Bolder Surgical, a Colorado-based developer of advanced energy vessel sealing and dissection devices, for approximately $160 million and has completed the previously announced transaction. The acquisition adds laparoscopic vessel sealing, dividing and dissecting devices (including pediatric-focused 3 mm and 5 mm tools) to Hologic’s Surgical portfolio, enabling capability expansion and broader commercialization into OB/GYN and hospital markets; Bolder was expected to generate about $10 million of product revenue in the calendar year.
-
ARCHIMED Diagnostics Acquires 60% Stake in ARK Diagnostics
October 28, 2025
Medical Devices
ARCHIMED Diagnostics (ARCHIMED’s diagnostics team) has acquired a 60% stake in Fremont-based ARK Diagnostics from Soulbrain Holdings in a transaction valuing ARK at $428 million. Soulbrain retains and reinvests in a 40% stake and the deal includes a joint-venture agreement to accelerate ARK’s product development and global expansion.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.